Charles River Laboratories Announces Third-Quarter 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. META
5. QQQ
6. LDOS
7. PLTR
8. CSCO
9. KTOS
10. NVDA

Go back to Charles River Laboratories Announces Third-Quarter 2022 Results

Charles River Laboratories (CRL) Announces Avian Vaccine Divestiture

November 2, 2022 7:21 AM EDT

Charles River Laboratories (NYSE: CRL) announced that it has signed a definitive agreement to divest its Avian Vaccine business for approximately $170 million in cash with potential contingent payments of up to an additional $30 million, subject to certain closing adjustments.

The Avian... More

Charles River Laboratories (CRL) Tops Q3 EPS by 9c, Offers Guidance

November 2, 2022 7:06 AM EDT

Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.63, $0.09 better than the analyst estimate of $2.54. Revenue for the quarter came in at $989.2 million versus the consensus estimate of $974.65 million.

GUIDANCE:

Charles River Laboratories sees FY2022 EPS of $10.80-$10.95, versus the consensus of... More